Paper358764
Verapamil and pulmonary hypertension.
Landmark K and 3 others. Acta Med Scand, 1978. Cited by 87 papers, by iCite.
Cite this record
ConductScience Library. Verapamil and pulmonary hypertension. Papers, record 358764. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/358764
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hypertension, Pulmonary | Major topic |
| Verapamil | Major topic |
| Adult | |
| Aged | |
| Arterioles | |
| Blood Pressure | |
| Cardiac Output | |
| Clinical Trials as Topic | |
| Drug Evaluation | |
| Female | |
| Heart Rate | |
| Humans | |
| Male | |
| Middle Aged | |
| Myocardial Contraction | |
| Pulmonary Circulation |
Source PubMed
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37298685 | MicroRNA and lncRNA as the Future of Pulmonary Arterial Hypertension Treatment. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37298685 | PubMed |
| 36336743 | Clinical evaluation of nebulized verapamil in out-patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease. | Clin Respir J | 2022 | https://conductscience.org/library/papers/36336743 | PubMed |
| 7442300 | Primary pulmonary hypertension: modern approaches to an old problem. | Lung | 1980 | https://conductscience.org/library/papers/7442300 | PubMed |
| 7013775 | Haemodynamic effects of prostacyclin (PGI2) in pulmonary hypertension. | Br Heart J | 1981 | https://conductscience.org/library/papers/7013775 | PubMed |
| 6831336 | Calcium blockers for cardiac disease: therapeutic implications. | Can Med Assoc J | 1983 | https://conductscience.org/library/papers/6831336 | PubMed |
| 6743418 | Detrimental effects of verapamil in patients with primary pulmonary hypertension. | Br Heart J | 1984 | https://conductscience.org/library/papers/6743418 | PubMed |
| 6652000 | Haemodynamic response to intravenous hydralazine in patients with pulmonary hypertension. | Br Heart J | 1983 | https://conductscience.org/library/papers/6652000 | PubMed |
| 6648866 | Effects of verapamil on pulmonary haemodynamics during hypoxaemia, at rest, and during exercise in patients with chronic obstructive pulmonary disease. | Thorax | 1983 | https://conductscience.org/library/papers/6648866 | PubMed |
| 6131809 | Calcium antagonists. Pharmacodynamic effects and mechanism of action. | Drugs | 1983 | https://conductscience.org/library/papers/6131809 | PubMed |
| 3765606 | Severe pulmonary hypertension in a patient with rheumatoid arthritis--response to nifedipine. | West J Med | 1986 | https://conductscience.org/library/papers/3765606 | PubMed |
| 2868878 | Drug treatment of primary pulmonary hypertension. | Drugs | 1986 | https://conductscience.org/library/papers/2868878 | PubMed |
| 1989744 | Calcium-channel blockers and anaesthesia. | Can J Anaesth | 1991 | https://conductscience.org/library/papers/1989744 | PubMed |
| 1883661 | The treatment of primary pulmonary hypertension. | Br Heart J | 1991 | https://conductscience.org/library/papers/1883661 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/358764
GET https://conductscience.org/api/papers/v1/358764/authors